The research of ReportLinker analysed leading companies in pharmaceutical contract manufacturing. This report provides revenues to 2026 for the world pharmaceutical contract manufacturing organisations (CMO) market.
The demand for outsourced drug production has grown rapidly in the past 10 years. The world market for pharma contract manufacturing was worth $61.6 billion in 2015, having grown by more than 6% from 2014.
The new study predicts strong growth in that industry’s revenue, reaching $84.0 billion worldwide in 2020, with further expansion expected.
Leading pharmaceutical contract manufacturing organizations profiled in this report are:
- Evonik Degussa
- Royal DSM
- Boehringer Ingelheim
- Teva API
- Esteve Quimica
- Zhejiang Hisun Pharmaceuticals
- Zhejiang Huahai Pharmaceuticals
- Shandong Xinhua Pharmaceuticals
- Aurobindo Pharma
- Divis Laboratories
- Dr. Reddy’s Laboratories